Parth Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-10-2024
- Paid Up Capital ₹ 0.84 M
as on 23-10-2024
- Company Age 40 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 122.11%
(FY 2023)
- Profit 106.25%
(FY 2023)
- Ebitda 178.70%
(FY 2023)
- Net Worth 14.36%
(FY 2023)
- Total Assets 25.58%
(FY 2023)
About Parth Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.84 M, as per Ministry of Corporate Affairs (MCA) records.
Ranjan Shah, Arun Dave, Ashok Dave, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231GJ1984PTC007147
- Company No.
007147
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Aug 1984
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Parth Laboratories Pvt Ltd offer?
Parth Laboratories Pvt Ltd offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Body Scrubs, Hand Sanitizers & Personal Hygiene, Toothpastes, Hair Care Products, Face Wash.
Who are the key members and board of directors at Parth Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranjan Shah  | Director | 15-Feb-2012 | Current |
| Arun Dave | Director | 08-Aug-1984 | Current |
| Ashok Dave | Director | 08-Aug-1984 | Current |
| Prakash Thakkar | Director | 08-Aug-1984 | Current |
Financial Performance and Corporate Structure Insights of Parth Laboratories.
Parth Laboratories Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 122.11% increase. The company also saw a substantial improvement in profitability, with a 106.25% increase in profit. The company's net worth Soared by an impressive increase of 14.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parth Laboratories?
In 2023, Parth Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Parth Laboratories?
Unlock and access historical data on people associated with Parth Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parth Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parth Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
